Biologics and Sterile
Drug Product Facilities
in North America

Whether your program needs drug substance, sterile drug product, or the device assembly, packaging, and cold storage that follows, it runs at the site equipped for that work under the same quality system.

Speak With an Expert

JON_CIOTTI_PHOTO_340_1__2_-removebg-preview

100%

regulatory inspection success rate across the network

600+

batches executed each year

Up to

2,000L

single-use bioreactor capacity

Over

square feet across three sites in Ohio and Ontario

Where Your Program Runs

We route your program to the site whose scale, licensure, and equipment fit it, and the program manager and technical lead stay with you from there.

West Chester, Ohio

Commercial sterile drug product at scale

Programs that need aseptic filling into vials, cartridges, or prefilled syringes run at our 580,000-square-foot commercially licensed site. Formulation and analytical and microbiology testing sit alongside the fill lines, and automated visual inspection, device assembly, and packaging follow, so a batch doesn't leave the site to be finished.

Explore West Chester

Blue Ash, Ohio

Finished product, packed and shipped

Our global headquarters handles commercial packaging today, and the 250,000-square-foot site is expanding through 2027 to add automated visual inspection, device assembly, labeling, and cold storage warehousing. It sits about ten miles from our West Chester site.

Explore Blue Ash

Toronto, Ontario

Biologics development, drug substance, and aseptic vial filling

Process and analytical development sit alongside drug substance manufacturing at this 136,000-square-foot site, in single-use bioreactors up to 2,000L. Formulation, aseptic fill/finish, cold storage, and logistics are on site, and the teams running them average 10+ years of tenure.

Explore Toronto

One quality system across three sites

100% regulatory inspection success rate across our network. The same digital quality management system and the same program oversight run at all three sites, which means a program that moves between them stays inside one quality system.

One program manager across every site

When your program runs drug substance at one site and fill/finish at another, the program manager and technical lead stay the same and the stage-gate checkpoints don't reset. Your team keeps one point of contact from the first gate to release.

A North American manufacturing footprint

Every site sits inside FDA and Health Canada jurisdiction, covered by the same inspection record. Our two Ohio facilities are about ten miles apart, so material, teams, and auditors move between them as a matter of routine.

Our Commitment to Sustainable Manufacturing Processes

Your procurement and ESG teams need supplier data they can put into their own reporting. In December 2025 we pledged to set science-based emissions reduction targets through the SBTi process, measured against a 2024 baseline, and we're building the Scope 1, 2, and 3 inventory that sits behind them.

Our targets go to SBTi for validation by the end of 2027. We maintain a scorecard with EcoVadis through annual assessments, and we're preparing to report environmental actions publicly through CDP.

FAQs

Where are Resilience's manufacturing facilities?

Resilience is a North American CDMO with manufacturing sites in West Chester, Ohio, for sterile drug product; Blue Ash, Ohio, for commercial packaging; and Toronto, Ontario, for biologics development, drug substance, and aseptic fill/finish.

Where does Resilience manufacture biologics drug substance?

Resilience manufactures biological drug substance at its Toronto, Ontario site, a 136,000-square-foot facility running single-use bioreactors up to 2,000L. Process and analytical development, formulation, and aseptic fill/finish are on the same campus.

Where does Resilience do sterile fill/finish?

Resilience runs aseptic fill/finish at both its West Chester, Ohio site and its Toronto, Ontario, site. West Chester is a 580,000-square-foot commercially licensed sterile drug product facility, filling vials, cartridges, and prefilled syringes at commercial scale.

Have Resilience's facilities been inspected by regulators?

Yes. Resilience holds a 100% regulatory inspection success rate across the network, covering FDA cGMP and pre-approval inspections, Health Canada, EMA, and PMDA, plus EU Annex 1 assessments. Its West Chester site is also certified to ISO 13485 for device assembly, and both West Chester and Toronto are commercially licensed.

Can I tour a Resilience facility?

Yes. Resilience hosts site tours in person and virtually, including for programs still evaluating manufacturing partners. Tell us which site and which part of the process you want to see, and we'll arrange it.

Biologics and Sterile
Drug Product Facilities
in North America